Companies: 10,795·Total market cap: $144.5T
Metsera, Inc.

Metsera, Inc.

MTSRNASDAQHealthcare
$70.50
$-0.25(-0.35%)
Market Cap$7.4B
P/E Ratio—
52W High$83.8599
52W Low$12.3
Cash on HandFinancialsRevenue

Metsera, Inc. (MTSR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MTSR · cash on hand · updated Dec 31, 2024

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$352.4M▲ +368.7% vs prior year
FY · as of Dec 31, 2024 · Reported in USD
Cash & Cash Equiv. (CCE)
$352.4M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+368.7%
vs prior fiscal year
Latest Quarter
$448.5M
Q3 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash & ST Investments$352.4MCash on Hand
Total Debt$9.8MTotal Debt
Net Cash / Net Debt+$342.6MNet Cash Position
Cash vs Debt Ratio
Cash 97%Debt 3%

Metsera, Inc. has a net cash position of $342.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$352.4M − $9.8M = +$342.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MTSR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2024Latest$352.4M+368.7%
Dec 31, 2023$75.2M—
MTSR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Metsera, Inc.
Metsera, Inc.YOU
MTSR
$352.4M4.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Metsera, Inc. (MTSR) cash on hand as of December 31, 2024 is $352.4M, comprising $352.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Metsera, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Metsera, Inc. cash reserves or cash position.

Metsera, Inc. annual cash on hand history shows increased +368.7% in 2024: increased +368.7% in 2024. Metsera, Inc. cash reserves in 2024 reflect the company's capital allocation strategy.

Metsera, Inc. carries total debt of $9.8M against cash of $352.4M, resulting in a net cash position of +$342.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MTSR cash on hand · 5 questions

As of December 31, 2024, Metsera, Inc. (MTSR) has $352,447,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $352,447,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (September 30, 2025): $448,461,000. Data sourced from the annual 10-K filing via FMP.

MTSR cash on handMTSR cash reservesMTSR cash 2024how much cash does MTSR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Metsera, Inc. · Metsera, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024